Swiss Group for Clinical Cancer Research
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sakk.ch/
Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
Phase 1
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 110
- Registration Number
- NCT00003902
- Locations
- 🇨🇭
Kantonsspital - St. Gallen, St. Gallen, Switzerland
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
Phase 3
Completed
- Conditions
- Leukemia
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 100
- Registration Number
- NCT00003746
- Locations
- 🇨🇭
Inselspital Bern, Bern, Switzerland
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
Phase 3
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 400
- Registration Number
- NCT00003215
- Locations
- 🇦🇹
Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
🇩🇪Dr. Horst-Schmidt-Kliniken, Wiesbaden, Germany
🇬🇷Saint Savvas Cancer Hospital of Athens, Athens, Greece
Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
Phase 2
Completed
- Conditions
- Malignant Mesothelioma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 61
- Registration Number
- NCT00030745
- Locations
- 🇨🇭
UniversitaetsSpital, Zurich, Switzerland
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Phase 3
Completed
- Conditions
- Lung Cancer
- Interventions
- Drug: ChemotherapyRadiation: RadiotherapyProcedure: Surgery
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 232
- Registration Number
- NCT00030771
- Locations
- 🇩🇪
Klinik Loewenstein gGmbH, Löwenstein, Germany
🇩🇪Klinikum der Stadt Mannheim, Mannheim, Germany
🇷🇸Institut za plucne bolesti, Sremska Kamenica, Serbia
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
Phase 3
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 319
- Registration Number
- NCT00030732
- Locations
- 🇦🇹
Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
🇮🇱Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
🇮🇹Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples, Italy
Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
Phase 3
Completed
- Conditions
- Myelodysplastic Syndromes
- Interventions
- Behavioral: Supportive care
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 86
- Registration Number
- NCT00004208
- Locations
- 🇨🇭
Universitaetsspital-Basel, Basel, Switzerland